Cointime

BlueWillow Biologics

company

About

BlueWillow is a biopharmaceutical company that focuses on developing and commercializing topical antiseptic and anti-infective products.

  • 11 - 50

Highlights

Total Funding Amount
$10M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series A
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Care,Medical,Nanotechnology
Founded date
Jan 1, 2000
Number Of Employee
11 - 50
Operating Status
Active

BlueWillow Biologics operates as a clinical-stage, privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and nose.

The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
BlueWillow Biologics has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on May 7, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 7, 2018 Series A $10M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
BlueWillow Biologics is funded by 2 investors. Line Moon Ventures and University of Michigan MINTS fund are the most recent investors.
Investor Name Lead Investor Funding Round
Line Moon Ventures — Series A
University of Michigan MINTS fund — Series A
Cointime
İçerikler
Şirket.